Table 3.
Clinical outcomes between the clopidogrel and the prasugrel/ticagrelor group before and after propensity score matching, HbA1C >6.5.
Clinical outcomes between the clopidogrel and the prasugrel/ticagrelor group before and after propensity score matching, HbA1C >6.5.